Eisenberg Evan R, Badlani Gopal H
Long Island Jewish Medical Center, 270-05 76th Avenue, New Hyde Park, NY 11040, USA.
Curr Urol Rep. 2004 Aug;5(4):287-94. doi: 10.1007/s11934-004-0052-4.
The gold standard for definitive management of symptomatic benign prostatic hypertrophy is transurethral resection of the prostate (TURP). Despite its efficacy, TURP has significant morbidity/mortality concerns such as hemorrhage and transurethral resection syndrome. This is especially worrisome for the medically high-risk patient, but the high rates of retrograde ejaculation found with TURP also pose a problem for young patients. A minimally invasive, outpatient alternative to TURP that has long-term efficacy, low morbidity/mortality, and provides a cost-effective advantage is in high demand. This review article discusses microwave thermotherapy as such an option and reports the long-term experience with the CoreTherm (CoreTherm Operations AB, Sweden) device.
有症状的良性前列腺增生症的确定性治疗的金标准是经尿道前列腺切除术（TURP）。尽管TURP疗效显著，但它存在诸如出血和经尿道切除综合征等重大的发病率/死亡率问题。这对于内科高风险患者尤其令人担忧，而且TURP发现的高逆行射精率对年轻患者也构成问题。人们迫切需要一种微创、门诊可用的替代TURP的方法，它具有长期疗效、低发病率/死亡率，并具有成本效益优势。这篇综述文章讨论了微波热疗作为这样一种选择，并报告了使用CoreTherm（瑞典CoreTherm Operations AB公司）设备的长期经验。
